Brain tumors significantly impact human health due to their complexity and the challenges in early detection and treatment. Accurate diagnosis is crucial for effective intervention, but existing methods often suffer from limitations in accuracy and efficiency. To address these challenges, this study presents a novel deep learning (DL) approach utilizing the EfficientNet family for enhanced brain tumor classification and detection. Leveraging a comprehensive dataset of 3064 T1‐weighted CE MRI images, our methodology incorporates advanced preprocessing and augmentation techniques to optimize model performance. The experiments demonstrate that EfficientNetB(07) achieved 99.14%, 98.76%, 99.07%, 99.69%, 99.07%, 98.76%, 98.76%, and 99.07% accuracy, respectively. The pinnacle of our research is the EfficientNetB3 model, which demonstrated exceptional performance with an accuracy rate of 99.69%. This performance surpasses many existing state‐of‐the‐art (SOTA) techniques, underscoring the efficacy of our approach. The precision of our high‐accuracy DL model promises to improve diagnostic reliability and speed in clinical settings, facilitating earlier and more effective treatment strategies. Our findings suggest significant potential for improving patient outcomes in brain tumor diagnosis.

Diabetes is a chronic metabolic disease characterized by elevated blood glucose levels and poses significant health risks, such as cardiovascular disease and cognitive damage. Understanding the causes of diabetes is crucial to managing it and preventing complications. The clinical community has a lot of diabetes diagnostic data. Machine learning algorithms may simplify finding hidden patterns, retrieving data from databases, and predicting outcomes. To tackle the challenge of designing an improved diabetes classification algorithm that is more accurate, random oversampling and hyper‐tuning parameter techniques have been used in this study. Whereas most of the existing methods were built upon considering any single dataset, for getting more acceptability in general, our proposed model has been designed based on two benchmark datasets: the BRFSS dataset, which has multiple classes, and the Diabetes 2019 dataset, which has binary classes. What is more, to improve the comprehensibility of the proposed model, a variety of explainability methodologies such as SHapley Additive Explanations (SHAP), Partial Dependency, and Local Interpretable Model‐agnostic Explanations (LIME) have been implemented which are not often noticed in the previous works. The detailed explainability charts will enable the end users or practitioners to understand the exact factors of any given diagnostic report. This research focused on classifying type 2 diabetes using machine learning and providing an explanation for the outcomes derived from the model predictions. Random oversampling and quantile transform are used to rectify imbalances in the dataset and guarantee the resilience of model training. By meticulously adjusting parameters with gridsearchCV, we successfully optimized our models to attain exceptional accuracy across binary and multi‐class datasets. We evaluate the proposed model using two datasets and performance metrics. The extra trees classifier (ET) performed exceptionally, achieving 97.23% accuracy on the multi‐class dataset and 97.45% on the binary dataset.